Hematology

The overall survival of patients with chronic lymphocytic leukemia (CLL) has improved significantly over the years; however, the clinical…

Prof. Alexander Röth (Chair), Prof. Wilma Barcellini, Prof. Josephine Vos and Prof. Bernd Jilma, will discuss about the evolving treatment paradigm in cold agglutinin disease (CAD): challenges and opportunities for optimal management.

An innovative session highlighting patient-focused decision-making and a dynamic debate on current 2L DLBCL treatment options.

This presentation offers insight into chimeric antigen receptor-transduced (CAR) natural killer (NK) cells, providing an update on the involvement of these cells in a host of topics, from stem cell transplantation to cancer.

This webinar discusses the critical factors involved in amyloidosis diagnosis, prognosis and management, describing both haematologic and organ responses to treatment. The presentation also delves into the origins of cardiac amyloidosis, outlining investigations required to assess organ involvement and establish a diagnosis.

This upcoming webinar discussion shares clinical insights from an expert in the use of direct oral anticoagulants for the treatment of…

Not able to attend the Expert Roundtable Discussion in Paris? Access the on-demand webcast here. This interactive event features expert perspectives on current and emerging uses of BTK inhibitors for CLL and MCL. Topics include:

Latest updates in Advanced Systemic Mastocytosis from EHA 2022. Targeting systemic mastocytosis. Update in Haematology session EHA 2022, Prof. Olivier Hermine introduces the  session on overcoming the challenges in diagnosis and management of advanced systemic macrocytosis.